OTC Markets EXMKT - Delayed Quote USD

Evolva Holding SA (ELVAF)

0.9000
0.0000
(0.00%)
At close: May 15 at 4:00:00 PM EDT
Currency in CHF All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
9,437.8000
15,539.4000
9,877.6000
Cost of Revenue
0
0
12,020.4000
21,548
19,183.5000
Gross Profit
0
0
-2,582.6000
-6,008.6000
-9,305.9000
Operating Expense
-788.6000
-788.6000
47,782
34,383.4000
32,723.6000
Operating Income
788.6000
788.6000
-50,364.6000
-40,392
-42,029.5000
Net Non Operating Interest Income Expense
67.1000
67.1000
-2,283.6000
-683.9000
-932.2000
Pretax Income
1,043.8000
1,043.8000
-105,229.4000
-43,366.4000
-41,407.5000
Tax Provision
0
0
0
0
-141.1000
Net Income Common Stockholders
1,043.8000
1,043.8000
-105,229.4000
-43,366.4000
-41,266.4000
Diluted NI Available to Com Stockholders
1,043.8000
1,043.8000
-105,229.4000
-43,366.4000
-41,266.4000
Basic EPS
0.14
0.14
-19.50
-10.00
-12.50
Diluted EPS
0.14
0.14
-19.50
-10.00
-12.50
Basic Average Shares
7,211.6000
7,211.6000
5,396.3000
4,281.2170
3,519.6020
Diluted Average Shares
7,211.6000
7,211.6000
5,396.3000
4,281.2170
3,519.6020
Total Operating Income as Reported
788.7000
788.7000
-92,245.3000
-40,392.1000
-42,029.5000
Total Expenses
-788.6000
-788.6000
59,802.4000
55,931.4000
51,907.1000
Net Income from Continuing & Discontinued Operation
1,043.8000
1,043.8000
-105,229.4000
-43,366.4000
-41,266.4000
Normalized Income
855.9000
855.9000
-48,664.1000
-44,027.1000
-41,189.0328
Interest Income
71.3000
71.3000
7.2000
76.8000
50.7000
Interest Expense
4.2000
4.2000
2,290.8000
760.7000
982.9000
Net Interest Income
67.1000
67.1000
-2,283.6000
-683.9000
-932.2000
EBIT
1,048
1,048
-102,938.6000
-42,605.7000
-40,424.6000
EBITDA
1,048
1,048
-98,357.4000
-34,517
-31,819.9000
Reconciled Cost of Revenue
0
0
12,020.4000
21,548
19,183.5000
Reconciled Depreciation
0
0
4,581.2000
8,088.7000
8,604.7000
Net Income from Continuing Operation Net Minority Interest
1,043.8000
1,043.8000
-105,229.4000
-43,366.4000
-41,266.4000
Total Unusual Items Excluding Goodwill
187.9000
187.9000
-56,565.3000
660.7000
-77.6000
Total Unusual Items
187.9000
187.9000
-56,565.3000
660.7000
-77.6000
Normalized EBITDA
860.1000
860.1000
-41,792.1000
-35,177.7000
-31,742.3000
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
-0.2328
12/31/2021 - 1/8/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

FBIOP Fortress Biotech, Inc.
6.61
+5.76%
 
ELTX Elicio Therapeutics, Inc.
5.32
-1.66%
 
NBY NovaBay Pharmaceuticals, Inc.
0.5800
-2.52%
 
VIGL Vigil Neuroscience, Inc.
2.3200
-2.11%
 
ATXI Avenue Therapeutics, Inc.
0.2101
-12.46%
 
CYCN Cyclerion Therapeutics, Inc.
2.9183
-3.05%
 
SCPX Scorpius Holdings, Inc.
0.0405
-17.01%
 
TRAW Traws Pharma, Inc.
1.1000
-11.29%
 
GANX Gain Therapeutics, Inc.
1.8100
-2.69%
 
APGE Apogee Therapeutics, Inc.
40.64
+1.98%